Bradshaw Curt 4
4 · NeuBase Therapeutics, Inc. · Filed Dec 2, 2020
Insider Transaction Report
Form 4
Bradshaw Curt
Chief Scientific Officer
Transactions
- Award
Employee stock option (right to buy)
2020-12-01+250,000→ 250,000 totalExercise: $7.61Exp: 2030-12-01→ Common stock (250,000 underlying)
Footnotes (1)
- [F1]1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive.